The filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.This is a known potential adverse event addressed in the product labeling.
|
Healthcare professional (hcp) reported patient was injected in ck 1, ck 4 and ck 3 area, on the zygomatic bone, lateral cheek area and chin area with [unspecified] dermal filler.Patient had a swollen blood vessel above the zygomatic area.Patient was treated with hyalase the affected area due to a suspected pressure on the vessel.The event is ongoing.
|